{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T15:27:46Z","timestamp":1726759666892},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,11,15]],"date-time":"2012-11-15T00:00:00Z","timestamp":1352937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00296-012-2547-5","type":"journal-article","created":{"date-parts":[[2012,11,14]],"date-time":"2012-11-14T05:50:54Z","timestamp":1352872254000},"page":"2937-2941","source":"Crossref","is-referenced-by-count":6,"title":["No evidence for involvement of the toll-like receptor (TLR) 4 gene Asp299Gly and Thr399Ile polymorphisms in susceptibility to primary gouty arthritis"],"prefix":"10.1007","volume":"33","author":[{"given":"Yu-Feng","family":"Qing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Guo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Guang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cui-Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Ping","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,15]]},"reference":[{"key":"2547_CR1","doi-asserted-by":"crossref","unstructured":"Richette P, Bardin T (2010) Gout. Lancet 375:318\u2013328","DOI":"10.1016\/S0140-6736(09)60883-7"},{"key":"2547_CR2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1742-1241.2009.02188.x","volume":"64","author":"JF Baker","year":"2010","unstructured":"Baker JF, Schumacher HR (2010) Update on gout and hyperuricemia. Int J Clin Pract 64:371\u2013377","journal-title":"Int J Clin Pract"},{"issue":"Suppl 5","key":"2547_CR3","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.3949\/ccjm.75.Suppl_5.S9","volume":"75","author":"AL Weaver","year":"2008","unstructured":"Weaver AL (2008) Epidemiology of gout. Cleve Clin J Med 75(Suppl 5):S9\u2013S12","journal-title":"Cleve Clin J Med"},{"key":"2547_CR4","first-page":"1859","volume":"35","author":"Z Miao","year":"2008","unstructured":"Miao Z, Li C, Chen Y et al (2008) Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 35:1859\u20131864","journal-title":"J Rheumatol"},{"key":"2547_CR5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/ard.2007.076232","volume":"67","author":"L Annemans","year":"2008","unstructured":"Annemans L, Spaepen E, Gaskin M et al (2008) Gout in the UK and Germany: prevalence, comorbidies and management in general practice 2000\u20132005. Ann Rheum Dis 67:960\u2013966","journal-title":"Ann Rheum Dis"},{"key":"2547_CR6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/BOR.0b013e3282f33f87","volume":"20","author":"A Taniguchi","year":"2008","unstructured":"Taniguchi A, Kammatani N (2008) Control of renal uric acid excretion and gout. Curr Opin Rheumatol 20:192\u2013197","journal-title":"Curr Opin Rheumatol"},{"key":"2547_CR7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01991","volume":"425","author":"Y Shin","year":"2003","unstructured":"Shin Y, Evans JE, Rock KL (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516\u2013521","journal-title":"Nature"},{"key":"2547_CR8","doi-asserted-by":"crossref","unstructured":"Ghaemi-Oskouie F, Shi Y (2011) The role of uric acid as an endogenous danger signal in immunity and inflammation. Curr Rheumatol Rep 13:160\u2013166","DOI":"10.1007\/s11926-011-0162-1"},{"key":"2547_CR9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/rheumatology\/ken460","volume":"48","author":"N Dalbeth","year":"2009","unstructured":"Dalbeth N, Merriman T (2009) Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout. Rheumatology (Oxford) 48:222\u2013226","journal-title":"Rheumatology (Oxford)"},{"key":"2547_CR10","doi-asserted-by":"crossref","first-page":"e1000504","DOI":"10.1371\/journal.pgen.1000504","volume":"5","author":"M Kolz","year":"2009","unstructured":"Kolz M, Johnson T, Sanna S et al (2009) Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 5:e1000504","journal-title":"PLoS Genet"},{"key":"2547_CR11","first-page":"421","volume":"22","author":"ZM Miao","year":"2006","unstructured":"Miao ZM, Zhao SH, Wang YG et al (2006) Epidemiological survey of hyperuricemia and gout in coastal areas of Shandong province. Chin J Endocrinol Metab 22:421\u2013425","journal-title":"Chin J Endocrinol Metab"},{"key":"2547_CR12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","volume":"27","author":"F Martinon","year":"2009","unstructured":"Martinon F, Mayor A, Tschopp J (2009) The inflammasomes: guardians of the body. Annu Rev Immunol 27:229\u2013265","journal-title":"Annu Rev Immunol"},{"key":"2547_CR13","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","volume":"282","author":"A Poltorak","year":"1998","unstructured":"Poltorak A, He X, Smirnova I (1998) Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene. Science 282:2085\u20132088","journal-title":"Science"},{"key":"2547_CR14","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.4049\/jimmunol.162.7.3749","volume":"162","author":"K Hoshino","year":"1999","unstructured":"Hoshino K, Takeuchi O, Kawai T (1999) Toll-like receptor 4 (TLR4)\u2013deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162:3749\u20133752","journal-title":"J Immunol"},{"key":"2547_CR15","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4049\/jimmunol.164.2.558","volume":"164","author":"K Ohashi","year":"2000","unstructured":"Ohashi K, Burkart V, Flohe S et al (2000) Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 164:558\u2013561","journal-title":"J Immunol"},{"key":"2547_CR16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20001858","volume":"195","author":"C Termeer","year":"2002","unstructured":"Termeer C, Benedix F, Sleeman J et al (2002) Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor4. J Exp Med 195:99\u2013111","journal-title":"J Exp Med"},{"key":"2547_CR17","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1074\/jbc.M100099200","volume":"276","author":"Y Okamura","year":"2001","unstructured":"Okamura Y, Watari M, Jerud ES et al (2001) The extra domain A of Wbronectin activates toll-like receptor 4. J Biol Chem 276:10229\u201310233","journal-title":"J Biol Chem"},{"key":"2547_CR18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/76048","volume":"25","author":"NC Arbour","year":"2000","unstructured":"Arbour NC, Lorenz E, Schutte BC et al (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187\u2013191","journal-title":"Nat Genet"},{"key":"2547_CR19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJMoa012673","volume":"347","author":"S Kiechl","year":"2002","unstructured":"Kiechl S, Lorenz E, Reindl M et al (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347:185\u2013192","journal-title":"N Engl J Med"},{"key":"2547_CR20","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1084\/jem.20022078","volume":"197","author":"C Erridge","year":"2003","unstructured":"Erridge C, Stewart J, Poxton IR (2003) Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J Exp Med 197:1787\u20131791","journal-title":"J Exp Med"},{"key":"2547_CR21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/art.20114","volume":"50","author":"TR Radstake","year":"2004","unstructured":"Radstake TR, Franke B, Hanssen S et al (2004) The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and\/or outcome. Arthr Rheum 50:999\u20131001","journal-title":"Arthr Rheum"},{"key":"2547_CR22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000260417","volume":"81","author":"X Shen","year":"2010","unstructured":"Shen X, Shi R, Zhang H et al (2010) The Toll-like receptor 4 D299G and T399I polymorphisms are associated with Crohn\u2019s disease and ulcerative colitis: a meta-analysis. Digestion 81:69\u201377","journal-title":"Digestion"},{"key":"2547_CR23","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","volume":"20","author":"SL Wallace","year":"1977","unstructured":"Wallace SL, Robinson H, Masi AT et al (1977) Preliminary criteria for the classification of the acute arthritis of the acute arthritis of primary gout. Arthr Rheum 20:895\u2013900","journal-title":"Arthr Rheum"},{"key":"2547_CR24","doi-asserted-by":"crossref","first-page":"e1948","DOI":"10.1371\/journal.pone.0001948","volume":"3","author":"K Stark","year":"2008","unstructured":"Stark K, Reinhard W, Neureuther K et al (2008) Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study. PLoS ONE 3:e1948","journal-title":"PLoS ONE"},{"key":"2547_CR25","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1111\/j.1582-4934.2010.01127.x","volume":"14","author":"L Yu","year":"2010","unstructured":"Yu L, Wang L, Chen S (2010) Endogenous toll-like receptor ligands and their biological significance. J Cell Mol Med 14:2592\u20132603","journal-title":"J Cell Mol Med"},{"key":"2547_CR26","first-page":"340","volume":"21","author":"R Kilding","year":"2003","unstructured":"Kilding R, Akil M, Till S, Amos R, WinWeld J, Iles MM et al (2003) A biologically important single nucleotide polymorphism within the toll-like receptor-4 gene is not associated with rheumatoid arthritis. Clin Exp Rheumatol 21:340\u2013342","journal-title":"Clin Exp Rheumatol"},{"key":"2547_CR27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1399-0039.2004.00162.x","volume":"63","author":"E Sanchez","year":"2004","unstructured":"Sanchez E, Orozco G, Lopez-Nevot MA, Jimenez-Alonso J, Martin J (2004) Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 63:54\u201357","journal-title":"Tissue Antigens"},{"key":"2547_CR28","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1136\/ard.2007.083337","volume":"67","author":"FJ Sheedy","year":"2008","unstructured":"Sheedy FJ, Marinou I, O\u2019Neill LAJ, Wilson AG (2008) The Mal\/TIRAP S180L and TLR4 G299D polymorphisms are not associated with susceptibility to or severity of rheumatoid arthritis. Ann Rheum Dis 67:1328\u20131331","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2547-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-012-2547-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2547-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T19:49:37Z","timestamp":1687808977000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-012-2547-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,15]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["2547"],"URL":"https:\/\/doi.org\/10.1007\/s00296-012-2547-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,15]]}}}